These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10215283)

  • 1. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension.
    Celentano A; Mancini FP; Crivaro M; Palmieri V; Ferrara LA; De Stefano V; Di Minno G; de Simone G
    Am J Cardiol; 1999 Apr; 83(8):1196-200. PubMed ID: 10215283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.
    Pontremoli R; Sofia A; Tirotta A; Ravera M; Nicolella C; Viazzi F; Bezante GP; Borgia L; Bobola N; Ravazzolo R; Sacchi G; Deferrari G
    J Am Soc Nephrol; 1996 Dec; 7(12):2550-8. PubMed ID: 8989733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients.
    Perticone F; Ceravolo R; Cosco C; Trapasso M; Zingone A; Malatesta P; Perrotti N; Tramontano D; Mattioli PL
    J Am Coll Cardiol; 1997 Feb; 29(2):365-9. PubMed ID: 9014990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension.
    Gharavi AG; Lipkowitz MS; Diamond JA; Jhang JS; Phillips RA
    Am J Cardiol; 1996 Jun; 77(15):1315-9. PubMed ID: 8677872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene.
    Hernández D; Lacalzada J; Rufino M; Torres A; Martín N; Barragán A; Barrios Y; Macía M; de Bonis E; Lorenzo V; Rodríguez A; González-Posada JM; Salido E
    Kidney Int; 1997 Apr; 51(4):1205-11. PubMed ID: 9083287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of the angiotensin I converting enzyme insertion/deletion polymorphism, plasma angiotensin converting enzyme activity, and left ventricular mass in a normotensive Chilean population.
    Jalil JE; Piddo AM; Cordova S; Chamorro G; Braun S; Jalil R; Vega J; Jadue'P L; Lavandero S; Lastra P
    Am J Hypertens; 1999 Jul; 12(7):697-704. PubMed ID: 10411367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes.
    Kasikcioglu E; Kayserilioglu A; Ciloglu F; Akhan H; Oflaz H; Yildiz S; Peker I
    Heart Vessels; 2004 Nov; 19(6):287-93. PubMed ID: 15799176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis.
    Dellgren G; Eriksson MJ; Blange I; Brodin LA; Rådegran K; Sylvén C
    Am J Cardiol; 1999 Oct; 84(8):909-13. PubMed ID: 10532509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
    Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
    Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cardiovascular risk factors on relation between angiotensin converting enzyme-gene polymorphism and blood pressure in arterial hypertension.
    Celentano A; Mancini FP; Crivaro M; Palmieri V; De Stefano V; Ferrara LA; Di Minno G; de Simone G
    J Hypertens; 1998 Jul; 16(7):985-91. PubMed ID: 9794739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1,919 subjects.
    Kimura M; Yokota M; Fujimura T; Kato S; Hirayama H; Tsunekawa A; Maeda M; Inagaki H; Ogawa S; Nakashima N; Yamada Y
    Cardiology; 1997; 88(4):309-14. PubMed ID: 9197423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT dispersion and left ventricular hypertrophy in athletes: relationship with angiotensin-converting enzyme I/D polymorphism.
    Tanriverdi H; Kaftan HA; Evrengul H; Dursunoglu D; Turgut G; Kiliç M
    Acta Cardiol; 2005 Aug; 60(4):387-93. PubMed ID: 16128371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure.
    Andersson B; Sylvén C
    J Am Coll Cardiol; 1996 Jul; 28(1):162-7. PubMed ID: 8752809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.
    Lindpaintner K; Lee M; Larson MG; Rao VS; Pfeffer MA; Ordovas JM; Schaefer EJ; Wilson AF; Wilson PW; Vasan RS; Myers RH; Levy D
    N Engl J Med; 1996 Apr; 334(16):1023-8. PubMed ID: 8598840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy.
    Iwai N; Ohmichi N; Nakamura Y; Kinoshita M
    Circulation; 1994 Dec; 90(6):2622-8. PubMed ID: 7994801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus.
    Estacio RO; Jeffers BW; Havranek EP; Krick D; Raynolds M; Schrier RW
    Am J Hypertens; 1999 Jun; 12(6):637-42. PubMed ID: 10371375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
    Rugale C; du Cailar G; Ribstein J; Mimran A
    Arch Mal Coeur Vaiss; 2003; 96(7-8):772-5. PubMed ID: 12945221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymorphic markers I/D and G7831A of angiotensin-I-converting enzyme gene and left ventricular hypertrophy in patients with essential hypertension].
    Brazhnik VA; Gorashko NM; Minushkina LO; Zateĭshchikov DA; Zateĭshchikova AA; Nosikov VV; Sidorenko BA
    Kardiologiia; 2003; 43(2):44-9. PubMed ID: 12891272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease.
    Osono E; Kurihara S; Hayama N; Sakurai Y; Ohwada K; Onoda N; Takeuchi M; Tomizawa T; Komaba Y; Hashimoto K; Matsunobu S; Yoneshima H; Iino Y
    Am J Kidney Dis; 1998 Nov; 32(5):725-30. PubMed ID: 9820440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.